Almirall, the international pharmaceutical company based in Spain, has signed a co-marketing agreement with Pfizer by which Pfizer grants Almirall commercialisation rights in Spain of a new medicine that combines amlodipine and atorvastatin under the trademark Astucor.
The details can be read here.
No comments:
Post a Comment